|
Video: What is a Stock Split?
|
|
Cocrystal Pharma is a biotechnology company engaged in discovering and developing antiviral therapeutics as treatments for serious and/or chronic viral diseases. Co. is developing antiviral therapeutics that inhibit the viral replication function of RNA viruses causing acute and chronic viral diseases. Co.'s targets include treating influenza virus, coronavirus and norovirus infections by discovering and developing drug candidates targeting the viral replication process. Additionally, Co. is targeting to decrease the duration of Hepatitis C virus (HCV) therapy by developing its drug candidate targeting HCV RNA-dependent RNA polymerase enzyme through partnerships and/or licensing activities. According to our COCP split history records, Cocrystal Pharma has had 1 split. | |
|
Cocrystal Pharma (COCP) has 1 split in our COCP split history database. The split for COCP took place on October 11, 2022. This was a 1 for 12 reverse split, meaning for each 12 shares of COCP owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 83.3333333333333 share position following the split.
When a company such as Cocrystal Pharma conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the COCP split history from start to finish, an original position size of 1000 shares would have turned into 83.3333333333333 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Cocrystal Pharma shares, starting with a $10,000 purchase of COCP, presented on a split-history-adjusted basis factoring in the complete COCP split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/22/2014 |
|
End date: |
04/17/2024 |
|
Start price/share: |
$4.80 |
|
End price/share: |
$1.43 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-70.21% |
|
Average Annual Total Return: |
-11.41% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$2,979.44 |
|
Years: |
9.99 |
|
|
|
Date |
Ratio |
10/11/2022 | 1 for 12 |
|
|